ChrysCapital is set to acquire a majority stake in Novartis India from Novartis AG, marking its first major pharma investment and triggering a mandatory open offer under takeover regulations.
ChrysCapital is set to acquire a majority stake in Novartis India from Novartis AG, marking its first major pharma investment and triggering a mandatory open offer under takeover regulations.